Cachexia is Prevalent in Patients with Hepatocellular Carcinoma and Associated with Worse Prognosis
Cancer cachexia is a wasting syndrome associated with functional impairment and reduced survival that impacts up to 50% of patients with gastrointestinal cancers. However, data are limited on the prevalence and clinical significance of cachexia in patients with hepatocellular carcinoma (HCC).
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Nicole E. Rich, Samuel Phen, Nirali Desai, Sukul Mittal, Adam C. Yopp, Ju Dong Yang, Jorge A. Marrero, Puneeth Iyengar, Rodney E. Infante, Amit G. Singal Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | Liver Cancer